scholarly journals Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema

2021 ◽  
Vol 10 (14) ◽  
pp. 28
Author(s):  
Pravin U. Dugel ◽  
Arshad M. Khanani ◽  
Brian B. Berger ◽  
Sunil Patel ◽  
Mitchell Fineman ◽  
...  
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Dose Escalation ◽  
Phase 1 ◽  
Plasma Kallikrein ◽  
Dose Escalation Study ◽  
Kallikrein Inhibitor

A Randomized, Dose-Escalation Study of Subconjunctival and Intravitreal Injections of Sirolimus in Patients with Diabetic Macular Edema

Ophthalmology ◽  
2012 ◽  
Vol 119 (1) ◽  
pp. 124-131 ◽  
Author(s):  
Pravin U. Dugel ◽  
Mark S. Blumenkranz ◽  
Julia A. Haller ◽  
George A. Williams ◽  
Wayne A. Solley ◽  
...  
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Dose Escalation ◽  
Intravitreal Injections ◽  
Dose Escalation Study

One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-Involved Diabetic Macular Edema and Reduced Vision

2019 ◽  
Vol 3 (12) ◽  
pp. 1107-1109 ◽  
Author(s):  
Jennifer K. Sun ◽  
Raj K. Maturi ◽  
David S. Boyer ◽  
John A. Wells ◽  
Victor H. Gonzalez ◽  
...  
Keyword(s):  
Macular Edema ◽  
Intravitreal Injection ◽  
Diabetic Macular Edema ◽  
Plasma Kallikrein ◽  
Kallikrein Inhibitor

scholarly journals Inhibition of Complement C3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results

2021 ◽  
Author(s):  
Charles C. Wykoff ◽  
Vrinda Hershberger ◽  
David Eichenbaum ◽  
Erin Henry ◽  
Husam S. Younis ◽  
...  
Keyword(s):  
Dose Escalation ◽  
Phase 1 ◽  
Geographic Atrophy ◽  
Complement C3 ◽  
Dose Escalation Study ◽  
Study Results
Sign in / Sign up

Export Citation Format

Share Document